12 results on '"Van, Henricus L."'
Search Results
2. Which patients benefit from adding short-term psychodynamic psychotherapy to antidepressants in the treatment of depression? A systematic review and meta-analysis of individual participant data.
- Author
-
Driessen, Ellen, Fokkema, Marjolein, Dekker, Jack J. M., Peen, Jaap, Van, Henricus L., Maina, Giuseppe, Rosso, Gianluca, Rigardetto, Sylvia, Cuniberti, Francesco, Vitriol, Veronica G., Andreoli, Antonio, Burnand, Yvonne, López Rodríguez, Jaime, Villamil Salcedo, Valerio, Twisk, Jos W. R., Wienicke, Frederik J., and Cuijpers, Pim
- Subjects
BRIEF psychotherapy ,ANTIDEPRESSANTS ,ONLINE information services ,PSYCHOLOGY information storage & retrieval systems ,MEDICAL databases ,META-analysis ,MEDICAL information storage & retrieval systems ,SYSTEMATIC reviews ,PSYCHODYNAMIC psychotherapy ,TREATMENT effectiveness ,SEVERITY of illness index ,MENTAL depression ,RESEARCH funding ,COMBINED modality therapy ,PATIENT care ,MEDLINE ,EVALUATION ,ADULTS - Abstract
Background: Adding short-term psychodynamic psychotherapy (STPP) to antidepressants increases treatment efficacy, but it is unclear which patients benefit specifically. This study examined efficacy moderators of combined treatment (STPP + antidepressants) v. antidepressants for adults with depression. Methods: For this systematic review and meta-analysis (PROSPERO registration number: CRD42017056029), we searched PubMed, PsycINFO, Embase.com, and the Cochrane Library from inception to 1 January 2022. We included randomized clinical trials comparing combined treatment (antidepressants + individual outpatient STPP) v. antidepressants in the acute-phase treatment of depression in adults. Individual participant data were requested and analyzed combinedly using mixed-effects models (adding Cochrane risk of bias items as covariates) and an exploratory machine learning technique. The primary outcome was post-treatment depression symptom level. Results: Data were obtained for all seven trials identified (100%, n = 482, combined: n = 238, antidepressants: n = 244). Adding STPP to antidepressants was more efficacious for patients with high rather than low baseline depression levels [ B = −0.49, 95% confidence interval (CI) −0.61 to −0.37, p < 0.0001] and for patients with a depressive episode duration of >2 years rather than <1 year (B = −0.68, 95% CI −1.31 to −0.05, p = 0.03) and than 1–2 years (B = −0.86, 95% CI −1.66 to −0.06, p = 0.04). Heterogeneity was low. Effects were replicated in analyses controlling for risk of bias. Conclusions: To our knowledge, this is the first study that examines moderators across trials assessing the addition of STPP to antidepressants. These findings need validation but suggest that depression severity and episode duration are factors to consider when adding STPP to antidepressants and might contribute to personalizing treatment selection for depression. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. A demonstration of a multi-method variable selection approach for treatment selection: Recommending cognitive–behavioral versus psychodynamic therapy for mild to moderate adult depression.
- Author
-
Cohen, Zachary D., Kim, Thomas T., Van, Henricus L., Dekker, Jack J. M., and Driessen, Ellen
- Subjects
PATIENT selection ,PSYCHODYNAMIC psychotherapy ,ANXIETY sensitivity ,COGNITIVE therapy - Abstract
Objective: We use a new variable selection procedure for treatment selection which generates treatment recommendations based on pre-treatment characteristics for adults with mild-to-moderate depression deciding between cognitive behavioral (CBT) versus psychodynamic therapy (PDT). Method: Data are drawn from a randomized comparison of CBT versus PDT for depression (N = 167, 71% female, mean-age = 39.6). The approach combines four different statistical techniques to identify patient characteristics associated consistently with differential treatment response. Variables are combined to generate predictions indicating each individual's optimal-treatment. The average outcomes for patients who received their indicated treatment versus those who did not were compared retrospectively to estimate model utility. Results: Of 49 predictors examined, depression severity, anxiety sensitivity, extraversion, and psychological treatment-needs were included in the final model. The average post-treatment Hamilton-Depression-Rating-Scale score was 1.6 points lower (95%CI = [0.5:2.8]; d = 0.21) for those who received their indicated-treatment compared to non-indicated. Among the 60% of patients with the strongest treatment recommendations, that advantage grew to 2.6 (95%CI = [1.4:3.7]; d = 0.37). Conclusions: Variable selection procedures differ in their characterization of the importance of predictive variables. Attending to consistently-indicated predictors may be sensible when constructing treatment selection models. The small N and lack of separate validation sample indicate a need for prospective tests before this model is used. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Correction: Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy.
- Author
-
Kool, Marit, Van, Henricus L., Bartak, Anna, de Maat, Saskia C. M., Arntz, Arnoud, van den Eshof, Johanna W., Peen, Jaap, Blankers, Matthijs, Bosmans, Judith E., and Dekker, Jack J. M.
- Subjects
- *
PSYCHODYNAMIC psychotherapy , *BRIEF psychotherapy , *PERSONALITY disorders , *PSYCHOTHERAPY , *COMORBIDITY , *FACTORIALS - Abstract
Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy. Block randomization The sentence currently reads: Patients will then be randomized by one of two research department employees in one of four groups (with a 1:1:1:1 allocation) using a computer script performing block randomization (25 vs 50-sessions; ST vs SPSP). [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
5. Cognitive-Behavioral Versus Psychodynamic Therapy for Major Depression: Secondary Outcomes of a Randomized Clinical Trial.
- Author
-
Driessen, Ellen, Don, Frank J., Cuijpers, Pirn, Van, Henricus L., Peen, Jaap, Twisk, Jos W. R., and Dekker, Jack J. M.
- Subjects
MENTAL depression ,THERAPEUTICS ,COGNITIVE therapy ,PSYCHODYNAMIC psychotherapy - Abstract
In a randomized clinical trial, we compared the efficacy of cognitive-behavioral therapy (CBT) and psychodynamic therapy for adult outpatient depression on measures of psychopathology, interpersonal functioning, pain, and quality of life. Method: There were 341 Dutch adults (70.1% female, mean age = 38.9, SD = 10.3) meeting Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition (DSM-IV) criteria for a major depressive episode and with a Hamilton Depression Rating Scale (HAM-D) score ≥14, who were randomized to 16 sessions of individual manualized CBT or short-term psychodynamic supportive psychotherapy. Severely depressed patients (HAM-D >24) received additional antidepressant medication according to a protocol. Outcome measures included the Brief Symptom Inventory, Beck Anxiety Inventory, Outcome Questionnaire, a visual analogue scale for pain, and EuroQol. Data were analyzed with mixed model analyses using intention-to-treat samples. Noninferiority margins were prespecified as Cohen's d = -0.30. Results: Across treatment conditions, 45-60% of the patients who completed posttreatment assessment showed clinically meaningful change for most outcome measures. We found no significant differences between the treatment conditions on any of the outcome measures at both posttreatment and follow-up. Noninferiority of psychodynamic therapy to CBT was shown for posttreatment and follow-up anxiety measures as well as for posttreatment pain and quality of life measures, but could not be consistently demonstrated for the other outcomes. Conclusions: This is the first study that shows that psychodynamic therapy can be at least as efficacious as CBT for depression on important aspects of patient functioning other than depressive symptom reduction. These findings extend the evidence-base of psychodynamic therapy for depression, but replication is needed by means of rigorously designed noninferiority trials. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. What Is the Best Sequential Treatment Strategy in the Treatment of Depression? Adding Pharmacotherapy to Psychotherapy or Vice Versa?
- Author
-
Dekker, Jack, Van, Henricus L., Hendriksen, Mariëlle, Koelen, Jurrijn, Schoevers, Robert A., Kool, S., van Aalst, G., and Peen, Jaap
- Subjects
- *
THERAPEUTICS , *MENTAL depression , *DRUG therapy , *PSYCHODYNAMIC psychotherapy , *TREATMENT effectiveness , *ANTIDEPRESSANTS , *PATHOLOGICAL psychology , *SYMPTOMS , *OUTPATIENT medical care - Abstract
Background: Insufficient response to monotreatment for depression is a common phenomenon in clinical practice. Even so, evidence indicating how to proceed in such cases is sparse. Methods: This study looks at the second phase of a sequential treatment algorithm, in which 103 outpatients with moderately severe depression were initially randomized to either short-term supportive psychodynamic therapy (PDT) or antidepressants. Patients who reported less than 30% symptom improvement after 8 weeks were offered combined treatment. Outcome measures were the Hamilton Depression Rating Scale (HAM-D), the Clinical Global Impression of Severity and Improvement, the SCL-90 depression subscale and the EuroQOL questionnaire. Results: Despite being nonresponsive, about 40% of patients preferred to continue with monotherapy. At treatment termination, patients initially randomized to PDT had improved more than those initially receiving antidepressants, as indicated by the HAM-D and the EuroQOL, independently of whether the addition was accepted or not. Conclusions: Starting with psychotherapy may be preferable in mildly and moderately depressed outpatients. For patients who receive either PDT or antidepressants, combined therapy after early nonresponse seems to be helpful. Nevertheless, this sequential strategy is not always preferred by patients. Copyright © 2012 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Interrater reliability in unbalanced designs: A comment on Scholte et al. (2009).
- Author
-
Polak, Marike, Abraham, Robert E., Van, Henricus L., and Ingenhoven, Theo
- Subjects
PERSONALITY studies ,PSYCHODYNAMICS ,QUANTITATIVE research ,METHODOLOGY ,PSYCHODYNAMIC psychotherapy - Abstract
In this article the authors discuss aspects of a study on the insufficient interrater reliability of psychodynamic diagnostics in personality research. The authors state that the study which reports insufficient interrater reliability which contradicts another study that shows sufficient interrater reliability for scoring the levels of Development Profile (DP) . Also discussed are the paradox of the findings, methodogical flaw, and methodological limitations involve in reliability studies.
- Published
- 2010
- Full Text
- View/download PDF
8. Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial.
- Author
-
Driessen, Ellen, Van, Henricus L., Schoevers, Robert A., Cuijpers, Pim, Van Aalst, Gerda, Don, Frank J., Hendriksen, Mariëlle, Kool, Simone, Molenaar, Pieter J., Peen, Jaap, and Dekker, Jack J. M.
- Subjects
- *
BEHAVIOR therapy , *PSYCHODYNAMIC psychotherapy , *MENTAL depression , *THERAPEUTICS , *PSYCHOTHERAPY , *PSYCHIATRY - Abstract
Background: Previous research has shown that Short Psychodynamic Supportive Psychotherapy (SPSP) is an effective alternative to pharmacotherapy and combined treatment (SPSP and pharmacotherapy) in the treatment of depressed outpatients. The question remains, however, how Short Psychodynamic Supportive Psychotherapy compares with other established psychotherapy methods. The present study compares Short Psychodynamic Supportive Psychotherapy to the evidence-based Cognitive Behavioral Therapy in terms of acceptability, feasibility, and efficacy in the outpatient treatment of depression. Moreover, this study aims to identify clinical predictors that can distinguish patients who may benefit from either of these treatments in particular. This article outlines the study protocol. The results of the study, which is being currently carried out, will be presented as soon as they are available. Methods/Design: Adult outpatients with a main diagnosis of major depressive disorder or depressive disorder not otherwise specified according to DSM-IV criteria and mild to severe depressive symptoms (Hamilton Depression Rating Scale score = 14) are randomly allocated to Short Psychodynamic Supportive Psychotherapy or Cognitive Behavioral Therapy. Both treatments are individual psychotherapies consisting of 16 sessions within 22 weeks. Assessments take place at baseline (week 0), during the treatment period (week 5 and 10) and at treatment termination (week 22). In addition, a follow-up assessment takes place one year after treatment start (week 52). Primary outcome measures are the number of patients refusing treatment (acceptability); the number of patients terminating treatment prematurely (feasibility); and the severity of depressive symptoms (efficacy) according to an independent rater, the clinician and the patient. Secondary outcome measures include general psychopathology, general psychotherapy outcome, pain, health-related quality of life, and cost-effectiveness. Clinical predictors of treatment outcome include demographic variables, psychiatric symptoms, cognitive and psychological patient characteristics and the quality of the therapeutic relationship. Discussion: This study evaluates Short Psychodynamic Supportive Psychotherapy as a treatment for depressed outpatients by comparing it to the established evidence-based treatment Cognitive Behavioral Therapy. Specific strengths of this study include its strong external validity and the clinical relevance of its research aims. Limitations of the study are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
9. Therapist Judgment of Defense Styles and Therapeutic Technique Related to Outcome in Psychodynamic Psychotherapy for Depression.
- Author
-
Hendriksen, Mariëlle, Van, Henricus L., Schoevers, Robert A., de Jonghe, Frans E.R.E.R., Gijsbers van Wijk, Cecile M.T., Peen, Jaap, and Dekker, Jack J.M.
- Subjects
- *
LETTERS to the editor , *PSYCHODYNAMIC psychotherapy , *THERAPEUTICS , *MENTAL depression - Abstract
No abstract available Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
10. Moderation of the Alliance-Outcome Association by Prior Depressive Episodes: Differential Effects in Cognitive-Behavioral Therapy and Short-Term Psychodynamic Supportive Psychotherapy.
- Author
-
Lorenzo-Luaces, Lorenzo, Driessen, Ellen, DeRubeis, Robert J., Van, Henricus L., Keefe, John R., Hendriksen, Mariëlle, and Dekker, Jack
- Subjects
- *
MENTAL depression , *THERAPEUTICS , *COGNITIVE therapy , *PSYCHOTHERAPY , *SYMPTOMS , *RANDOMIZED controlled trials , *BRIEF psychotherapy , *COMPARATIVE studies , *RESEARCH methodology , *MEDICAL cooperation , *PSYCHODYNAMIC psychotherapy , *QUESTIONNAIRES , *RESEARCH , *DISEASE relapse , *EVALUATION research , *TREATMENT effectiveness - Abstract
Prior studies have suggested that the association between the alliance and depression improvement varies as a function of prior history of depression. We sought to replicate these findings and extend them to short-term psychodynamic supportive psychotherapy (SPSP) in a sample of patients who were randomized to one of these treatments and were administered the Helping Alliance Questionnaire (N=282) at Week 5 of treatment. Overall, the alliance was a predictor of symptom change (d=0.33). In SPSP, the alliance was a modest but robust predictor of change, irrespective of prior episodes (d=0.25-0.33). By contrast, in CBT, the effects of the alliance on symptom change were large for patients with 0 prior episodes (d=0.86), moderate for those with 1 prior episode (d=0.49), and small for those with 2+ prior episodes (d=0.12). These findings suggest a complex interaction between patient features and common vs. specific therapy processes. In CBT, the alliance relates to change for patients with less recurrent depression whereas other CBT-specific processes may account for change for patients with more recurrent depression. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis update.
- Author
-
Driessen, Ellen, Hegelmaier, Lisa M., Abbass, Allan A., Barber, Jacques P., Dekker, Jack J.M., Van, Henricus L., Jansma, Elise P., and Cuijpers, Pim
- Subjects
- *
PSYCHODYNAMIC psychotherapy , *THERAPEUTICS , *MENTAL depression , *META-analysis , *CLINICAL trials , *PATHOLOGICAL psychology , *FOLLOW-up studies (Medicine) , *ANTIDEPRESSANTS - Abstract
Objectives The efficacy of short-term psychodynamic psychotherapy (STPP) for depression is debated. Recently, a number of large-scale and high-quality studies have been conducted. We examined the efficacy of STPP by updating our 2010 meta-analysis. Results After a thorough literature search, 54 studies (33 randomized clinical trials) totaling 3946 subjects were included. STPP was significantly more effective than control conditions at post-treatment on depression, general psychopathology and quality of life measures ( d = 0.49 to 0.69). STPP pre-treatment to post-treatment changes ( d = 0.57 to 1.18) indicated significant improvements on all outcome measures, which either significantly improved further ( d = 0.20 to 1.04) or were maintained from post-treatment to follow-up. No significant differences were found between individual STPP and other psychotherapies at post-treatment ( d = − 0.14) and follow-up ( d = − 0.06) in analyses that were adequately powered to detect a clinically relevant difference. STPP was significantly more efficacious than other psychotherapies on anxiety measures at both post-treatment ( d = 0.35) and follow-up ( d = 0.76). Conclusion We found clear indications that STPP is effective in the treatment of depression in adults. Although more high-quality studies are needed, particularly to assess the efficacy of STPP compared to control conditions at follow-up and to antidepressants, these findings add to the evidence-base of STPP for depression. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
12. The efficacy of adding short-term psychodynamic psychotherapy to antidepressants in the treatment of depression: A systematic review and meta-analysis of individual participant data.
- Author
-
Driessen, Ellen, Dekker, Jack J.M., Peen, Jaap, Van, Henricus L., Maina, Giuseppe, Rosso, Gianluca, Rigardetto, Sylvia, Cuniberti, Francesco, Vitriol, Veronica G., Florenzano, Ramon U., Andreoli, Antonio, Burnand, Yvonne, López-Rodríguez, Jaime, Villamil-Salcedo, Valerio, Twisk, Jos W.R., and Cuijpers, Pim
- Subjects
- *
PSYCHODYNAMIC psychotherapy , *BRIEF psychotherapy , *META-analysis , *ANTIDEPRESSANTS , *TREATMENT effectiveness , *PSYCHOTHERAPY - Abstract
We examined the efficacy of adding short-term psychodynamic psychotherapy (STPP) to antidepressants in the treatment of depression by means of a systematic review and meta-analysis of individual participant data, which is currently considered the most reliable method for evidence synthesis. A thorough systematic literature search resulted in 7 studies comparing combined treatment of antidepressants and STPP versus antidepressant mono-therapy (n = 3) or versus antidepressants and brief supportive psychotherapy (n = 4). Individual participant data were obtained for all these studies and totaled 482 participants. Across the total sample of studies, combined treatment of antidepressants and STPP was found significantly more efficacious in terms of depressive symptom levels at both post-treatment (Cohen's d = 0.26, SE = 0.10, p =.01) and follow-up (d = 0.50, SE = 0.10, p <.001). This effect was most apparent at follow-up and in studies examining STPP's specific treatment efficacy. Effects were still apparent in analyses that controlled for risk of bias and STPP quality in the primary studies. These findings support the evidence-base of adding STPP to antidepressants in the treatment of depression. However, further studies are needed, particularly assessing outcome measures other than depression and cost-effectiveness, as well as examining the relative merits of STPP versus other psychotherapies as added to antidepressants. • Short-term psychodynamic psychotherapy (STPP) is a treatment for depression. • Adding STPP to antidepressants results in lower depressive symptom levels. • This effect is small at post-treatment and moderate at follow-up. • This effect can be related to STPP's specific treatment components. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.